Concepedia

Ruifeng Shi

RS

Statistics

Publications

24

Citations

629

H-Index

16

Active since

2000

Affiliations

Tianjin Medical University General Hospital(Current)

The University of Texas Southwestern Medical Center

Nanjing General Hospital of Nanjing Military Command

Nanjing Medical University

Nanjing University

Ruifeng Shi is an author at Tianjin Medical University General Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2000–2025

24

Publications

24

EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells

Hao Gong, Yuan Yin, Weiting Li et al. · BMC Cancer · 2020 · 68 citations · Full text

, , +17

ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer

Guangsheng Zhu, Ruifeng Shi, Zihe Zhang et al. · Frontiers in Immunology · 2021 · 68 citations · Full text

, , +17

Neutrophil-to-Lymphocyte Ratio Predicts Length of Stay and Acute Hospital Cost in Patients with Acute Ischemic Stroke

Lingling Zhao, Qiliang Dai, Xiangliang Chen et al. · Journal of Stroke and Cerebrovascular Diseases · 2016 · 47 citations

, , +10

Effect of peer support on diabetes distress: a cluster randomized controlled trial

Changping Ju, Ruifeng Shi, X. Ye et al. · Diabetic Medicine · 2018 · 41 citations

, , +17

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer

Weiting Li, Hongbing Zhang, M. Liu et al. · Journal of Cancer · 2021 · 37 citations · Full text

, , +14

1–5 of 24